Figure S6. Performance of the different multi-protein panels in the Berlin and Munich cohorts.

(A) ROC Curves for the Berlin cohort. First samples are taken for each patient when their severity level reached 6 or 7 on the WHO scale, whereas the last sample was taken before discharge or death. Here, the single histidine-rich glycoprotein protein has reasonable performance, whereas the multi-protein panels have comparable and better performance. (B) ROC curves of the linear SVM trained on the Munich cohort as reported by Geyer et al.